MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Rapport Therapeutics’ RAP-219 Hits Phase II Goals in Bipolar Mania Trial ↗
Via MarketBeat
Tickers RAPP
Exposures Product Safety
News headline image
Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approval ↗
Via MarketBeat
Tickers IRD
Exposures Product Safety
News headline image
Adagene Eyes Phase II Data for Masked CTLA-4 Therapy in MSS Colorectal Cancer ↗
Via MarketBeat
Tickers ADAG
Exposures Product Safety
Abake Mensah Preserves Island Memory Through School Fairs, Markets, And Family Tables
Via GlobePRwire
Topics Product Recall
Exposures Legal Product Safety
Peter Thiel, OpenAI Back Brain Implant Firm Targeting Cancer
Via Investor Brand Network
Exposures Product Safety
News headline image
Zero Ad Dollars, 100% Reputation: How Mark Lehman's Power Access Control Scaled to an $8–$10M Empire
Via 24-7 Press Release
Topics Product Recall
Exposures Legal Product Safety
News headline image
Palvella Therapeutics Eyes QTORIN Launch as Rare-Disease Pipeline Expands ↗
Via MarketBeat
Tickers PVLA
Exposures Product Safety
News headline image
Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
Tickers EXEL
Exposures Financial Intellectual Property Legal
News headline image
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening ↗
Via MarketBeat
Topics Artificial Intelligence Intellectual Property
Tickers CV
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Korean Skin Rejuvenation: PRP, PRF, Exosomes & RF Microneedling Options Released
Via Press Release Distribution Service
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III ↗
Via MarketBeat
Tickers VRTX
Exposures Product Safety
News headline image
Perspective Therapeutics Posts 72% 18-Month PFS in VMT-α-NET Study Update ↗
Via MarketBeat
Tickers CATX
Exposures Product Safety
News headline image
BBNX Investor Alert: Beta Bionics, Inc. Stockholders with Large Losses Should Contact Robbins LLP About Leading the Securities Class Action Lawsuit
Via Newsfile
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
CCHR Urges the FDA to Follow UK Warnings on Antidepressant Suicide Risk and Persistent Sexual Dysfunction
Via 24-7 Press Release
Exposures Product Safety
News headline image
Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in Revenue ↗
Via The Motley Fool
Tickers BMY PFE
Exposures COVID-19 Product Safety
News headline image
Blue Sky Laser & Tox Introduces XERF Skin Tightening and becoming the first provider in Arlington, Virginia
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Seek a Leadership Role Before November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
PeptideSuppliers.tech Explains How It Scores 400+ Peptide Manufacturers and Suppliers
Via PRLog
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Why Biohaven Catapulted 30%-Plus — And Why It Might Not Be Done Sprinting ↗
Via Investor's Business Daily
Tickers RY TSX:RY
Exposures Product Safety
News headline image
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility ↗
Via The Motley Fool
Tickers BMY NVO
Exposures Product Safety
News headline image
NuYOU360 Ventures LLC Publishes Four-Question Standard for Evaluating At-Home Light Therapy Devices
Via AB Newswire
Exposures Product Safety
News headline image
WAVE Life Sciences Highlights Obesity Data, FDA-Aligned RNA Editing Path ↗
Via MarketBeat
Tickers WVE
Exposures Product Safety
News headline image
Diabeloop announces the completion of its balance sheet restructuring and looks ahead to the next phase of its development
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Food Plant Cleaning Details Quarterly and Emergency Pathogen Response Services
Via Press Advantage
Exposures Product Safety
News headline image
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
Via B2i Digital
Tickers UNCY
Exposures Product Safety
News headline image
Playroom Architect Addresses Water Beads Hidden in Squishy Toys Following Recent Recalls, Offers Sensory Play Safety Guidance
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
News headline image
HER2-Positive Gastric Cancer Market Forecast to Reach US$2.05 Billion by 2035 as First-Line Treatment Options Expand | Report by DataM Intelligence
Via Press Release Distribution Service
Topics Death
Exposures Death Product Safety
News headline image
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
Via Newsfile
Tickers NTHI
Exposures Product Safety
News headline image
AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue? ↗
Via The Motley Fool
Topics Intellectual Property
Tickers ABBV BMY
Exposures Intellectual Property Product Safety
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in 486-Patient Heart Attack Detection Study
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story